Chromocell Therapeutics Corp Quarterly Common Stock, Shares Authorized from Q4 2022 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Chromocell Therapeutics Corp quarterly Common Stock, Shares Authorized history and growth rate from Q4 2022 to Q2 2024.
  • Chromocell Therapeutics Corp Common Stock, Shares Authorized for the quarter ending June 30, 2024 was 200M shares.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 200M Jun 30, 2024 10-Q 2024-08-13
Q1 2024 200M Mar 31, 2024 10-Q 2024-05-15
Q4 2023 200M +100M +100% Dec 31, 2023 10-Q 2024-08-13
Q4 2022 100M Dec 31, 2022 10-K 2024-04-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.